BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150
21 results:

  • 1. Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian cancer: Systematic Review and Meta-Analysis.
    Wang Q; Chang Z; Liu X; Wang Y; Feng C; Ping Y; Feng X
    J Med Internet Res; 2024 Jan; 26():e48527. PubMed ID: 38252469
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma.
    Kim K; Kim SH; Lee JY; Kim YN; Lee ST; Park E
    J Gynecol Oncol; 2023 Jul; 34(4):e45. PubMed ID: 36807748
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
    Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
    Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.
    Xu Y; Xie C; Gao Z; Zhang M; Zhan M
    Medicine (Baltimore); 2022 Sep; 101(38):e30627. PubMed ID: 36197166
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Scand J Gastroenterol; 2021 Aug; 56(8):965-971. PubMed ID: 34165379
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Analysis of PARP inhibitors induced anemia in advanced and relapsed epithelial ovarian cancer].
    Zeng J; Li N; Yuan GW; Sun YC; Zhang R; Li XG; Zuo J; Li N; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):401-407. PubMed ID: 34154315
    [No Abstract]    [Full Text] [Related]  

  • 7. CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.
    Shiomi M; Matsuzaki S; Serada S; Matsuo K; Mizuta-Odani C; Jitsumori M; Nakae R; Matsuzaki S; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Ueda Y; Yoshino K; Naka T; Kimura T
    Cancer Sci; 2021 Sep; 112(9):3655-3668. PubMed ID: 34117815
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular cancer: An Observational Study.
    Ljungman L; Eriksson LE; Flynn KE; Gorman JR; Ståhl O; Weinfurt K; Wiklander M; Lampic C; Wettergren L
    J Sex Med; 2019 Jul; 16(7):1049-1059. PubMed ID: 31255211
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analysis of MRI Values and Hemoglobin and Total Protein Concentrations of Cystic Ovarian Tumors.
    Tanaka Y; Nakai G; Yamamura K; Yamamoto K; Narumi Y; Ohmichi M
    J Magn Reson Imaging; 2019 Apr; 49(4):1133-1140. PubMed ID: 30240525
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An Oncogenic
    Shimada Y; Kohno T; Ueno H; Ino Y; Hayashi H; Nakaoku T; Sakamoto Y; Kondo S; Morizane C; Shimada K; Okusaka T; Hiraoka N
    Oncologist; 2017 Feb; 22(2):158-164. PubMed ID: 28167572
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.
    Joerger M; Huitema AD; Koeberle D; Rosing H; Beijnen JH; Hitz F; Cerny T; Schellens JH; Gillessen S
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):113-24. PubMed ID: 24166106
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central cancer Treatment Group (NCCTG) randomized phase II study.
    Alberts SR; Foster NR; Morton RF; Kugler J; Schaefer P; Wiesenfeld M; Fitch TR; Steen P; Kim GP; Gill S
    Ann Oncol; 2005 Oct; 16(10):1654-61. PubMed ID: 16085692
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
    Chiara S; Tognoni A; Pastrone I; Tomasello L; Brema F; Di Costanzo G; Folco U; Pronzato P;
    Gynecol Oncol; 2004 May; 93(2):474-8. PubMed ID: 15099965
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin.
    Scheuba C; Kaserer K; Kotzmann H; Bieglmayer C; Niederle B; Vierhapper H
    Thyroid; 2000 May; 10(5):413-6. PubMed ID: 10884188
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas.
    Lee JE; Evans DB; Hickey RC; Sherman SI; Gagel RF; Abbruzzese MC; Abbruzzese JL
    Surgery; 1998 Dec; 124(6):1115-22. PubMed ID: 9854592
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Extrauterine low-grade endometrial stromal sarcoma: report of three cases.
    Fukunaga M; Ishihara A; Ushigome S
    Pathol Int; 1998 Apr; 48(4):297-302. PubMed ID: 9648159
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer.
    Frasci G; Contino A; Iaffaioli RV; Mastrantonio P; Conforti S; Persico G
    Gynecol Oncol; 1994 Feb; 52(2):154-60. PubMed ID: 8314132
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Craniopharyngioma--a long-term results following limited surgery and radiotherapy.
    Rajan B; Ashley S; Gorman C; Jose CC; Horwich A; Bloom HJ; Marsh H; Brada M
    Radiother Oncol; 1993 Jan; 26(1):1-10. PubMed ID: 8438080
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.